Skip to main content
. 2024 Oct 4;5(4):103328. doi: 10.1016/j.xpro.2024.103328

Table 1.

Summary of screening results using the method described in this protocol

PP1/PP2A target Type of modulator Compounds tested Confirmed hits (hit rate) Computed ligandability (P2Rank)
PP1:MYPT1-Ank inhibition 1,500 1 (0.07%) 8.8
PP1:Inhibitor-2 inhibition 1,500 0 (NA) 3.2
B56 (PP2A):LSPI-SliM inhibition 65,000 2 (0.003%) 2.4
PP1:SDS22 inhibition 65,000 0 (NA) 0
PP2A:B56 stimulation 500,000 3 (0.0006%) 1.6